CLINICAL RESEARCH: CLINICAL TRIALS
Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery
The Statins for Risk Reduction in Surgery (StaRRS) study
Kristin O'Neil-Callahan, MD ,
George Katsimaglis, MD*, ,
Micah R. Tepper, MD,
Jason Ryan, MD,
Carla Mosby, MD,
John P.A. Ioannidis, MD||,¶ and
Peter G. Danias, MD, PhD*,, ,*
* Cardiovascular Division
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
Second Cardiology Clinic, Hygeia Hospital, Athens, Greece
Naval Hospital, Athens, Greece
|| Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts
¶ Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
Manuscript received September 2, 2004;
revised manuscript received October 13, 2004,
accepted October 18, 2004.
* Reprint requests and correspondence: Dr. Peter G. Danias, Hygeia Hospital, 4 Erythrou Stavrou Street and Kifissias Avenue, Maroussi 15123 Greece
(Email: pdanias{at}hygeia.gr; pdanias{at}bidmc.harvard.edu).
OBJECTIVES: We sought to assess whether statins may decrease cardiac complications in patients undergoing noncardiac vascular surgery.
BACKGROUND: Cardiovascular complications account for considerable morbidity in patients undergoing noncardiac surgery. Statins decrease cardiac morbidity and mortality in patients with coronary disease, and the beneficial treatment effect is seen early, before any measurable increase in coronary artery diameter.
METHODS: A retrospective study recorded patient characteristics, past medical history, and admission medications on all patients undergoing carotid endarterectomy, aortic surgery, or lower extremity revascularization over a two-year period (January 1999 to December 2000) at a tertiary referral center. Recorded perioperative complication outcomes included death, myocardial infarction, ischemia, congestive heart failure, and ventricular tachyarrhythmias occurring during the index hospitalization. Univariate and multivariate logistic regressions identified predictors of perioperative cardiac complications and medications that might confer a protective effect.
RESULTS: Complications occurred in 157 of 1,163 eligible hospitalizations and were significantly fewer in patients receiving statins (9.9%) than in those not receiving statins (16.5%, p = 0.001). The difference was mostly accounted by myocardial ischemia and congestive heart failure. After adjusting for other significant predictors of perioperative complications (age, gender, type of surgery, emergent surgery, left ventricular dysfunction, and diabetes mellitus), statins still conferred a highly significant protective effect (odds ratio 0.52, p = 0.001). The protective effect was similar across diverse patient subgroups and persisted after accounting for the likelihood of patients to have hypercholesterolemia by considering their propensity to use statins.
CONCLUSIONS: Use of statins was highly protective against perioperative cardiac complications in patients undergoing vascular surgery in this retrospective study.
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | CAD = coronary artery disease | | CI = confidence interval | | MI = myocardial infarction | | OR = odds ratio |
|
This article has been cited by other articles:
|
|
|
|
 
American College of Cardiology Foundation, American Heart Association Task Force on Practice, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine, Society for Vascular Surgery, L. A. Fleisher, et al.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
J. Am. Coll. Cardiol.,
November 2, 2009;
(2009)
j.jacc.2009.07.010v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. POLDERMANS
Statins and noncardiac surgery: Current evidence and practical considerations
Cleveland Clinic Journal of Medicine,
November 1, 2009;
76(Suppl_4):
S79 - S83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Kothmann, A. M. Batterham, S. J. Owen, A. J. Turley, M. Cheesman, A. Parry, and G. Danjoux
Effect of short-term exercise training on aerobic fitness in patients with abdominal aortic aneurysms: a pilot study
Br. J. Anaesth.,
October 1, 2009;
103(4):
505 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Schouten, E. Boersma, S. E. Hoeks, R. Benner, H. van Urk, M. R.H.M. van Sambeek, H. J.M. Verhagen, N. A. Khan, M. Dunkelgrun, J. J. Bax, et al.
Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery
N. Engl. J. Med.,
September 3, 2009;
361(10):
980 - 989.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Landesberg, W. S. Beattie, M. Mosseri, A. S. Jaffe, and J. S. Alpert
Perioperative Myocardial Infarction
Circulation,
June 9, 2009;
119(22):
2936 - 2944.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Hoeks and D. Poldermans
CHAPTER 34 Non-cardiac Surgery in Cardiac Patients
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Isma, J. Barani, I. Mattiasson, B. Lindblad, and A. Gottsater
Lipid-Lowering Therapy is Related to Inflammatory Markers and 3-Year Mortality in Patients With Critical Limb Ischemia
Angiology,
October 1, 2008;
59(5):
542 - 548.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. S. FELDMAN and D. J. BROTMAN
Perioperative statins: More than lipid-lowering?
Cleveland Clinic Journal of Medicine,
September 1, 2008;
75(9):
654 - 662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Samson
The Role of Statin Drugs in the Management of the Peripheral Vascular Patient
Vascular and Endovascular Surgery,
August 1, 2008;
42(4):
352 - 366.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Gregoratos
Current Guideline-Based Preoperative Evaluation Provides the Best Management of Patients Undergoing Noncardiac Surgery
Circulation,
June 17, 2008;
117(24):
3134 - 3144.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Poldermans, S. E. Hoeks, and H. H. Feringa
Pre-Operative Risk Assessment and Risk Reduction Before Surgery
J. Am. Coll. Cardiol.,
May 20, 2008;
51(20):
1913 - 1924.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. I. Paraskevas
Applications of statins in cardiothoracic surgery: more than just lipid-lowering
Eur. J. Cardiothorac. Surg.,
March 1, 2008;
33(3):
377 - 390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Mittnacht, M. Fanshawe, and S. Konstadt
Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2008;
12(1):
33 - 59.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. O. McFalls, H. B. Ward, T. E. Moritz, F. S. Apple, S. Goldman, G. Pierpont, G. C. Larsen, B. Hattler, K. Shunk, F. Littooy, et al.
Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial
Eur. Heart J.,
February 1, 2008;
29(3):
394 - 401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Thielmann, M. Neuhauser, A. Marr, B. R. Jaeger, D. Wendt, B. Schuetze, M. Kamler, P. Massoudy, R. Erbel, and H. Jakob
Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
J. Thorac. Cardiovasc. Surg.,
November 1, 2007;
134(5):
1143 - 1149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
e159 - e242.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Circulation,
October 23, 2007;
116(17):
e418 - e500.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Perler
Should Statins Be Given Routinely Before Carotid Endarterectomy?
Perspectives in Vascular Surgery and Endovascular Therapy,
September 1, 2007;
19(3):
240 - 245.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Bronheim
Statins and the Perioperative Period
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2007;
11(3):
231 - 236.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Licker, J. Diaper, and C. Ellenberger
Perioperative {beta}-Blockade: Still Not Enough for Adequate Cardioprotection!
Anesth. Analg.,
July 1, 2007;
105(1):
278 - 279.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Le Manach, G. Godet, P. Coriat, C. Martinon, M. Bertrand, M.-H. Fleron, and B. Riou
The Impact of Postoperative Discontinuation or Continuation of Chronic Statin Therapy on Cardiac Outcome After Major Vascular Surgery
Anesth. Analg.,
June 1, 2007;
104(6):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Smetana
A 68-Year-Old Man With COPD Contemplating Colon Cancer Surgery
JAMA,
May 16, 2007;
297(19):
2121 - 2130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Howard-Alpe, J. W. Sear, and P. Foex
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers
Br. J. Anaesth.,
December 1, 2006;
97(6):
758 - 769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Schouten, J. J Bax, and D. Poldermans
Assessment of cardiac risk before non-cardiac general surgery
Heart,
December 1, 2006;
92(12):
1866 - 1872.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Collard, S. C. Body, S. K. Shernan, S. Wang, D. T. Mangano, and Multicenter Study of Perioperative Ischemia (MCSPI
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
J. Thorac. Cardiovasc. Surg.,
August 1, 2006;
132(2):
392 - 400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Auerbach and L. Goldman
Assessing and Reducing the Cardiac Risk of Noncardiac Surgery
Circulation,
March 14, 2006;
113(10):
1361 - 1376.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. London
Beta-Blockade in the Perioperative Period: Where Do We Stand After All the Trials?
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2006;
10(1):
17 - 23.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Karthikeyan and B Bhargava
Managing patients undergoing non-cardiac surgery: need to shift emphasis from risk stratification to risk modification
Heart,
January 1, 2006;
92(1):
17 - 20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Futterman and L. Lemberg
The Expanding Role of the HMG-CoA Reductase Inhibitor, The Most Widely Prescribed Drug in the World
Am. J. Crit. Care.,
November 1, 2005;
14(6):
555 - 558.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.J. Devereaux, L. Goldman, S. Yusuf, K. Gilbert, K. Leslie, and G. H. Guyatt
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review
Can. Med. Assoc. J.,
September 27, 2005;
173(7):
779 - 788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
